Back to matchesWe found a matchYour institution may have access to this item. Find your institution then sign in to continue.TitleTHE FIRST‐IN‐CLASS ETS INHIBITOR TK‐216 INTERFERES WITH ETS TRANSCRIPTION FACTORS AND SYNERGIZE WITH LENALIDOMIDE IN LYMPHOMA.AuthorsSpriano, F.; Chung, E.; Napoli, S.; Tarantelli, C.; Gaudio, E.; Cascione, L.; Cavalli, A.; Rinaldi, A.; Kwee, I.; Ye, H.; Rossi, D.; Zucca, E.; Stathis, A.; Jessen, K.; Lannutti, B.; Toretsky, J.; Bertoni, F.SubjectsTRANSCRIPTION factors; RNA helicase; ANAPLASTIC lymphoma kinase; CHIMERIC proteins; GENE expression profilingPublicationHematological Oncology, 2019, Vol 37, p322ISSN0278-0232Publication typeArticleDOI10.1002/hon.132_2630